Art. 60 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 31 Mar 2004cited 4×

At the request of the Commission, the Agency shall, in respect of authorised medicinal products, collect any available information on methods that Member States' competent authorities use to determine the added therapeutic value that any new medicinal product provides.

  • Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision

    It is apparent from Regulation No 726/2004 that the EMA is responsible for coordinating the existing scientific resources put at its disposal by the Member States for the evaluation, supervision and pharmacovigilance of medicinal products …

    5 May 2021 · 62018TJ0611

  • Opinion of Advocate General Medina delivered on 6 October 2022. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision

    Article 60 of Regulation No 726/2004 establishes: ‘At the request of the Commission, the [EMA] shall, in respect of authorised medicinal products, collect any available information on methods that Member States’ competent authorities …

    6 Oct 2022 · 62021CC0438

  • Judgment of the Court (Fourth Chamber) of 16 March 2023. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision

    Under Article 60 of that regulation: ‘At the request of the Commission, the [EMA] shall, in respect of authorised medicinal products, collect any available information on methods that Member States’ competent authorities use to …

    16 Mar 2023 · 62021CJ0438

  • Judgment of the Court (Third Chamber) of 22 June 2023. Federal Republic of Germany v European Commission.Decision

    Title IV of Regulation No 726/2004, entitled ‘The European Medicines Agency – Responsibilities and administrative structure’, includes a Chapter 1, itself entitled ‘Tasks of the agency’, comprising Articles 55 to 66 of that same …

    22 Jun 2023 · 62021CJ0006